Quick Summary:
In the ever-growing and dynamic healthcare sphere, achieving a comprehensive understanding of the market trends, key regional players and future outlooks is crucial for any forward-thinking business leader. The Global Malaria Diagnostics market is set to reach the significant milestone of $1.3 Billion by 2030, signalling a crucial investment opportunity.
Our cutting-edge Malaria Diagnostics market research report is tailored to arm decision-makers with key insights and data-driven strategies. Besides providing a detailed analysis on growth trajectories, including the promising expansion in the Microscopic Diagnostics segment, the report also paints a clear picture of the geographical markets, particularly focusing on the substantial growth in the U.S. and China. Accompanied with an exclusive focus on key competitors like Access Bio and Olympus Corporation, our report empowers you to make informed decisions to aid your business' growth in a competitive market landscape. Explore the future, one data point at a time.
Global Malaria Diagnostics Market to Reach $1.3 Billion by 2030
The global market for Malaria Diagnostics estimated at US$811.7 Million in the year 2022, is projected to reach a revised size of US$1.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2022-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$685.9 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Microscopic Diagnostics segment is readjusted to a revised 4.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $214.4 Million, While China is Forecast to Grow at 8.6% CAGR
The Malaria Diagnostics market in the U.S. is estimated at US$214.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$290 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.Select Competitors (Total 16 Featured) -
- Access Bio, Inc.
- Beckman Coulter, Inc.
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Leica Microsystems GmbH
- Nikon Corporation
- Olympus Corporation
- Premier Medical Corporation
- Siemens Healthineers
- Sysmex Partec GmbH
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Frequently Asked Questions about the Global Market for Malaria Diagnostics
What is the estimated value of the Global Market for Malaria Diagnostics?
The Global Market for Malaria Diagnostics was estimated to be valued at $811.7 Million in 2022.
What is the growth rate of the Global Market for Malaria Diagnostics?
The growth rate of the Global Market for Malaria Diagnostics is 6.1%, with an estimated value of $1300 Million by 2030.
What is the forecasted size of the Global Market for Malaria Diagnostics?
The Global Market for Malaria Diagnostics is estimated to be worth $1300 Million by 2030.
Who are the key companies in the Global Market for Malaria Diagnostics?
Key companies in the Global Market for Malaria Diagnostics include Access Bio, Inc., Beckman Coulter, Inc., bioMerieux SA, Bio, Rad Laboratories, Inc., Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, Premier Medical Corporation and Siemens Healthineers.
| Report Attribute | Details |
|---|---|
| No. of Pages | 162 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 811.7 Million |
| Forecasted Market Value ( USD | $ 1300 Million |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Malaria Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for Microscopic Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Rapid Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 13: World Malaria Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 14: USA Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 15: USA Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 16: USA 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
CANADA
- Table 17: Canada Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 18: Canada Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 19: Canada 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
JAPAN
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 20: Japan Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 21: Japan Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 22: Japan 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
CHINA
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 23: China Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 24: China Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 25: China 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
EUROPE
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 26: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 27: Europe Historic Review for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 28: Europe 16-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 29: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 30: Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 31: Europe 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
FRANCE
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 32: France Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 33: France Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 34: France 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
GERMANY
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 35: Germany Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 36: Germany Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 37: Germany 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
ITALY
- Table 38: Italy Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 39: Italy Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 40: Italy 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 41: UK Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 42: UK Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 43: UK 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
SPAIN
- Table 44: Spain Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 45: Spain Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 46: Spain 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
RUSSIA
- Table 47: Russia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 48: Russia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 49: Russia 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 50: Rest of Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 51: Rest of Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 52: Rest of Europe 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 54: Asia-Pacific Historic Review for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 55: Asia-Pacific 16-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
- Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 57: Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 58: Asia-Pacific 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
AUSTRALIA
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
- Table 59: Australia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 60: Australia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 61: Australia 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
INDIA
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
- Table 62: India Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 63: India Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 64: India 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
SOUTH KOREA
- Table 65: South Korea Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 66: South Korea Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 67: South Korea 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
REST OF ASIA-PACIFIC
- Table 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 69: Rest of Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 70: Rest of Asia-Pacific 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
LATIN AMERICA
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
- Table 71: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 72: Latin America Historic Review for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 73: Latin America 16-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
- Table 74: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 75: Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 76: Latin America 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
ARGENTINA
- Table 77: Argentina Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 78: Argentina Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 79: Argentina 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
BRAZIL
- Table 80: Brazil Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 81: Brazil Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 82: Brazil 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
MEXICO
- Table 83: Mexico Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 84: Mexico Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 85: Mexico 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
REST OF LATIN AMERICA
- Table 86: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 87: Rest of Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 88: Rest of Latin America 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
MIDDLE EAST
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
- Table 89: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 90: Middle East Historic Review for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 91: Middle East 16-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
- Table 92: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 93: Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 94: Middle East 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
IRAN
- Table 95: Iran Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 96: Iran Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 97: Iran 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
ISRAEL
- Table 98: Israel Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 99: Israel Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 100: Israel 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
SAUDI ARABIA
- Table 101: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 102: Saudi Arabia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 103: Saudi Arabia 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
UNITED ARAB EMIRATES
- Table 104: UAE Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 105: UAE Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 106: UAE 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
REST OF MIDDLE EAST
- Table 107: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 108: Rest of Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 109: Rest of Middle East 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
AFRICA
- Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
- Table 110: Africa Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 111: Africa Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 112: Africa 16-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2014, 2023 & 2030
Companies Mentioned
A selection of companies mentioned in this report includes:
- Access Bio, Inc.
- Beckman Coulter, Inc.
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Leica Microsystems GmbH
- Nikon Corporation
- Olympus Corporation
- Premier Medical Corporation
- Siemens Healthineers
- Sysmex Partec GmbH
